Administration, organization, priorities

MOBIX is administered by a board composed of the directors of each of the centres. One of the board members is elected to chair the board for a three year period. The Chairman of the Board is responsible to the community at large through the Vice-President Research for the operation of the Institute.

• MOBIX consists of a series of research centres, set up within the institute, each with its own experimental and development goals and all sharing the common vision. The Institute also houses the MOBIX lab, a central facility that provides molecular biology expertise and services to the research community, both inside and outside McMaster.
• MOBIX focuses on the development of molecular approaches for the detection and elucidation of pathogenic mechanisms and therapeutic interventions in chronic and acquired human disease, including cancer and infectious diseases.
• MOBIX pirority is rapidly moving research from concept to clinical trials.

About

The Institute has been established in 1986 in partnership with the university, Hamilton hospitals, government and industry to facilitate collaboration and communication across several areas of research. Working closely with local hospitals, the Institute provides opportunities for the implementation of new therapeutic initiatives. Approximately 10,000 disease target molecules have been identified in humans with no corresponding small molecule drug leads, indicating that a large market exists to create novel therapeutics and diagnostics. The institute is proud of its capacity to move a research idea from the proof of concept stage through pre-clinical developments into clinical trials in a seamless fashion. The Institute provides opportunities for internationally renowned scientists to come to McMaster to continue their work. Challenging learning opportunities are also provided for undergraduate, graduate and postdoctoral trainees at the Institute.